Bertram Glaß

98 papers receiving 4.6k citations

Bertram Glaß's Hit Papers

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial 2022 · 433 citations
4330+5+10Years since publication2505007501000

Peers

Bertram Glaß
Comparison fields: 5 of 96
  • Pathology and Forensic Medicine 2.4k
  • Oncology 2.3k
  • Genetics 857
  • Hematology 844
  • Neurology 821
Replace Luis F. Porrata with:
Luis F. Porrata United States
John Kuruvilla Canada
Sunita D. Nasta United States
Nicolas Ketterer Switzerland
Réda Bouabdallah France
V. Leblond France
Gustaaf W. van Imhoff Netherlands
Auayporn Nademanee United States
Craig S. Sauter United States
Mark Hertzberg Australia
Bertram Glaß relative to Luis F. Porrata United States Luis F. Porrata's profile →
Citations per field
00.5×3.3×
Luis F. Porrata · 1×
Citations per year

Countries citing papers authored by Bertram Glaß

Since Specialization
Citations

This map shows the geographic impact of Bertram Glaß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertram Glaß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertram Glaß more than expected).

Fields of papers citing papers by Bertram Glaß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertram Glaß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertram Glaß. The network helps show where Bertram Glaß may publish in the future.

Co-authors

The 25 scholars most cited alongside Bertram Glaß, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bertram Glaß Line = papers co-authored together Bertram Glaß links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
Hit paper breakdown →
20101138
2
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
Hit paper breakdown →
2022433
3
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era
Hit paper breakdown →
2010414
4 2016269
5
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
Hit paper breakdown →
2021232
6
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
Hit paper breakdown →
2022206
7 2012191
8
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
Hit paper breakdown →
2022173
9 2012152
10 2013139
11 201369
12 201462
13 200455
14 199751
15 199650
16 200448
17 202242
18 196142
19 201841
20 199539

About Bertram Glaß

Bertram Glaß is a scholar working on Pathology and Forensic Medicine, Oncology, Hematology, Genetics and Immunology, having authored 103 papers that have together received 4.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (42 papers), CAR-T cell therapy research (31 papers), Hematopoietic Stem Cell Transplantation (24 papers), Chronic Lymphocytic Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (14 papers), CNS Lymphoma Diagnosis and Treatment (9 papers), Immune Cell Function and Interaction (9 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.4k citations), Oncology (2.3k citations), Genetics (857 citations), Hematology (844 citations) and Neurology (821 citations). Bertram Glaß has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Norbert Schmitz, Michael Pfreundschuh, Marita Ziepert, Markus Loeffler, Christian Gisselbrecht, David C. Linch, Nicolas Ketterer, Marek Trněný, Devinder Gill and André Bosly. Their work appears in journals such as Blood, Bone Marrow Transplantation, Journal of Clinical Oncology, Annals of Hematology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact